To interrogate the topology of the COLBN as well as how the dysregulation of COLBN key drivers could relate to AD, we identified an in vitro experiment that perturbed a key driver gene in the COLBN, MYRF, and examined how the predicted network structures correspond to its identified experimental targets. Here, MYRF is linked to Alzheimer disease.